Norges Bank’s Sana Biotechnology SANA Stock Holding History

Norges Bank’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-189,979	Closed	-$790K	–	1897
2024 Q3	$790K	Sell	189,979 -59,642	-24%	-$313K	﹤0.01%	1754
2024 Q2	$1.36M	Hold	249,621	–	–	﹤0.01%	1782
2024 Q1	$2.5M	Hold	249,621	–	–	﹤0.01%	1718
2023 Q4	$1.02M	Hold	249,621	–	–	﹤0.01%	1862
2023 Q3	$966K	Hold	249,621	–	–	﹤0.01%	1892
2023 Q2	$1.49M	Hold	249,621	–	–	﹤0.01%	1895
2023 Q1	$816K	Hold	249,621	–	–	﹤0.01%	2022
2022 Q4	$986K	Hold	249,621	–	–	﹤0.01%	2057
2022 Q3	$1.5M	Hold	249,621	–	–	﹤0.01%	1952
2022 Q2	$1.61M	Buy	249,621 +220,751	+765%	+$1.41M	﹤0.01%	1922
2022 Q1	$238K	Hold	28,870	–	–	﹤0.01%	2134
2021 Q4	$447K	Buy	+28,870	New	+$557K	﹤0.01%	2150

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Norges Bank's SANA Position: Q4 2024 in Review

Norges Bank sold out of Sana Biotechnology (SANA) in Q4 2024, closing a stake of 189,979 shares — an estimated $790K sold.

Norges Bank first reported a position in SANA in Q4 2021 and held it in 12 quarters. The position peaked at $2.5M in Q1 2024. 164 funds tracked by Wall St. Rank hold SANA as of Q4 2024.

Norges Bank reported no remaining Sana Biotechnology position as of Q4 2024 after selling out during the quarter.
Norges Bank sold 189,979 Sana Biotechnology shares in Q4 2024, an estimated $790K.
Norges Bank first reported a position in Sana Biotechnology in Q4 2021 and held it in 12 quarters.
Norges Bank's Sana Biotechnology position peaked at $2.5M in Q1 2024.
164 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2024.

Based on Norges Bank's 13F filing for Q4 2024, filed 12 Feb 2025.